IGFBP2 and cancer: Mechanistic insights are still required to explain the cytotoxic effects we observed, but the identification of RBM11, CYP4F22 and IGFBP-2 as new potential drug targets for EFT would seem to confirm the utility of this open source, computational methodology for cancer drug discovery.